Chemed Co. (NYSE:CHE – Get Free Report) EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at approximately $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Chemed Price Performance
Shares of CHE opened at $572.39 on Monday. The firm has a market capitalization of $8.61 billion, a price-to-earnings ratio of 28.92, a PEG ratio of 2.43 and a beta of 0.46. The company has a 50-day moving average of $578.27 and a 200 day moving average of $565.05. Chemed Co. has a 1-year low of $523.33 and a 1-year high of $654.62.
Chemed (NYSE:CHE – Get Free Report) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $5.32 EPS. On average, equities analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.
Chemed Announces Dividend
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Chemed by 2.6% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company’s stock valued at $314,868,000 after purchasing an additional 14,651 shares in the last quarter. William Blair Investment Management LLC boosted its position in Chemed by 2.7% during the 2nd quarter. William Blair Investment Management LLC now owns 475,372 shares of the company’s stock valued at $257,927,000 after acquiring an additional 12,705 shares in the last quarter. State Street Corp increased its holdings in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after acquiring an additional 3,564 shares during the period. Geode Capital Management LLC raised its position in shares of Chemed by 4.9% in the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock worth $201,820,000 after acquiring an additional 15,791 shares in the last quarter. Finally, Impax Asset Management Group plc lifted its stake in shares of Chemed by 4.7% during the 3rd quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after purchasing an additional 14,814 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
CHE has been the subject of several recent analyst reports. Royal Bank of Canada dropped their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday.
View Our Latest Report on Chemed
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
- Five stocks we like better than Chemed
- What is the S&P 500 and How It is Distinct from Other Indexes
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- How to Invest in Biotech Stocks
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Trading Stocks: RSI and Why it’s Useful
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.